The Defining Electrophysiology Transaction of 1997-2005
Biosense, CARTO, and the Industrialization of Catheter Ablation Executive Summary The largest dedicated medtech transaction I could verify in the 1997-2005 window for cardiac ablation and electrophysiology mapping was Johnson & Johnson’s 1997 agreement to acquire Biosense for roughly $400 million in stock, followed by the 1998 combination of Biosense with Webster Laboratories to form […]
The Defining Electrophysiology Transaction of 1997-2005 Read More »